Reduction in coronary heart disease with atorvastatin independent of low-density lipoprotein cholesterol

被引：2

作者：

Takagi, Hisato ^{[1
]}

Umemoto, Takuya ^{[1
]}

机构：

[1] Shizuoka Med Ctr, Dept Cardiovasc Surg, Shizuoka 4118611, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 149卷 / 02期

关键词：

Atorvastatin; Coronary heart disease; Low-density lipoprotein cholesterol; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; DIABETES-MELLITUS; PRAVASTATIN; EFFICACY; OUTCOMES; CARE;

D O I：

10.1016/j.ijcard.2011.02.055

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：267 / 269

页数：4

共 20 条

[1]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

[2]

[Anonymous], 2000, Ital Heart J, V1, P810

[3]

[Anonymous], 2002, JAMA, V288, P2998

[4] Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].

Athyros, VG ;

Papageorgiou, AA ;

Mercouris, BR ;

Athyrou, VV ;

Symeonidis, AN ;

Basayannis, EO ;

Demitriadis, DS ;

Kontopoulos, AG .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228

[5] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].

Baigent, C. ;

Blackwell, L. ;

Emberson, J. ;

Holland, L. E. ;

Reith, C. ;

Bhala, N. ;

Peto, R. ;

Barnes, E. H. ;

Keech, A. ;

Simes, J. ;

Collins, R. .

LANCET, 2010, 376 (9753) :1670-1681

[6] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

[7] Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy [J].

Kizer, Jorge R. ;

Madias, Christopher ;

Wilner, Brian ;

Vaughan, Carl J. ;

Mushlin, Alvin I. ;

Trushin, Paula ;

Gotto, Antonio M., Jr. ;

Pasternak, Richard C. .

AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (09) :1289-1296

[8] Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) [J].

Knopp, Robert H. ;

D'Emden, Michael ;

Smilde, Johan G. ;

Pocock, Stuart J. .

DIABETES CARE, 2006, 29 (07) :1478-1485

[9] Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics - The ALLIANCE study [J].

Koren, MJ ;

Hunninghake, DB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1772-1779

[10] Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials [J].

Mills, E. J. ;

Wu, P. ;

Chong, G. ;

Ghement, I. ;

Singh, S. ;

Akl, E. A. ;

Eyawo, O. ;

Guyatt, G. ;

Berwanger, O. ;

Briel, M. .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2011, 104 (02) :109-124

← 1 2 →